Dergiler / Neurological sciences and neurophysiology (Online) / 2021 / Cilt: 38 - Sayı: 3

The Relationship between Early Neurological Deterioration, Poor Clinical Outcome, and Venous Collateral Score in Cerebral Venous Sinus Thrombosis

Sayfa
158–165
Yayın Tarihi
2022-10-19
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

This study highlights the clinical importance of venous collaterals; however, larger prospective multicenter studies are required to confirm the relationship with venous collaterals in patients with CVST.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background and Purpose: Cerebral venous sinus thrombosis (CVST) is one of the rare causes of cerebrovascular disease and has an extremely heterogeneous prognosis.
📊
Temel Bulgular & Veri:Materials and Methods: A total of 121 patients diagnosed with CVST between 2010 and 2020 were retrospectively included.
💡
Sonuç & Katkı:This study highlights the clinical importance of venous collaterals; however, larger prospective multicenter studies are required to confirm the relationship with venous collaterals in patients with CVST.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:2010 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Background and Purpose: Cerebral venous sinus thrombosis (CVST) is one of the rare causes of cerebrovascular disease and has an extremely heterogeneous prognosis. The aim of this study was to investigate the potential relationship between early neurological deterioration, poor clinical outcome in CVST and the venous collateral score. Materials and Methods: A total of 121 patients diagnosed with CVST between 2010 and 2020 were retrospectively included. The demographic, clinical, and radiological findings related to venous sinus thrombosis and early neurological deterioration were investigated in relation to the clinical outcome. Results: The factors associated with early neurological deterioration were superior sagittal sinus thrombosis (P < 0.001), sinus rectus thrombosis (P = 0.031), parenchymal lesions (P < 0.001), and venous collateral score (P < 0.001). The factors associated with poor clinical outcome were superior sagittal sinus thrombosis (P < 0.001), cortical vein thrombosis (P < 0.001), venous collateral score (P < 0.001), and initial clinical symptoms. Binary logistic regression analyses revealed poor clinical outcome as a significant variable, with a venous collateral scale of 0 or 1 as a risk factor for a poor outcome (significance of the modelP < 0.001). Conclusion: Early neurologic deterioration and poor clinical outcome may occur due to poor collateralization in CVST. Identifying the subgroup of CVST patients at risk of clinical deterioration is therefore important. This study highlights the clinical importance of venous collaterals; however, larger prospective multicenter studies are required to confirm the relationship with venous collaterals in patients with CVST.

🔖

Bu Makaleye Atıf Yap

BAKAR, M., HAKYEMEZ, B., DİNÇ, Y., ÖZPAR, R. (2022). The Relationship between Early Neurological Deterioration, Poor Clinical Outcome, and Venous Collateral Score in Cerebral Venous Sinus Thrombosis. Neurological sciences and neurophysiology (Online), Cilt: 38 - Sayı: 3, 158–165. https://ajindex.com/articles/584293

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Bousser MG, Crassard I. Cerebral venous thrombosis, pregnancy and oral contraceptives. Thromb Res 2012;130 Suppl 1:S19‑22
  2. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005;352:1791‑8
  3. Bousser MG, Ferro JM. Cerebral venous thrombosis: An update. Lancet Neurol 2007;6:162‑70
  4. Coutinho JM, Zuurbier SM, Aramideh M, Stam J. The incidence of cerebral venous thrombosis: A cross‑sectional study. Stroke 2012;43:3375‑7
  5. Dlamini N, Billinghurst L, Kirkham FJ. Cerebral venous sinus (sinovenous) thrombosis in children. Neurosurg Clin N Am 2010;21:511‑27
  6. Corvol JC, Oppenheim C, Manaï R, Logak M, Dormont D, Samson Y, et al. Diffusion‑weighted magnetic resonance imaging in a case of cerebral venous thrombosis. Stroke 1998;29:2649‑52
  7. Yoshikawa T, Abe O, Tsuchiya K, Okubo T, Tobe K, Masumoto T, et al. Diffusion‑weighted magnetic resonance imaging of dural sinus thrombosis. Neuroradiology 2002;44:481‑8
  8. Guenther G, Arauz A. Cerebral venous thrombosis: A diagnostic and treatment update. Neurologia 2011;26:488‑98. 9. de Bruijn SF, Stam J. Randomized, placebo‑controlled trial of anticoagulant treatment with low‑molecular‑weight heparin for cerebral sinus thrombosis. Stroke 1999;30:484‑8
  9. Coutinho JM, Stam J. How to treat cerebral venous and sinus thrombosis. J Thromb Haemost 2010;8:877‑83
  10. Coutinho J, de Bruijn SF, Deveber G, Stam J. Anticoagulation for cerebral venous sinus thrombosis. Cochrane Database Syst Rev 2011;2011:CD002005
  11. Saposnik G, Barinagarrementeria F, Brown RD Jr., Bushnell CD, Cucchiara B, Cushman M, et al. Diagnosis and management of cerebral venous thrombosis: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:1158‑92
  12. Qureshi AI. A classification scheme for assessing recanalization and collateral formation following cerebral venous thrombosis. J Vasc Interv Neurol 2010;3:1‑2
  13. Barboza MA, Mejías C, Colin‑Luna J, Quiroz‑Compean A, Arauz A. Intracranial venous collaterals in cerebral venous thrombosis: Clinical and imaging impact. J Neurol Neurosurg Psychiatry 2015;86:1314‑8
  14. Sheth SA, Trieu H, Liebeskind DS, Saver JL, Szeder V, Jahan R, et al. Venous collateral drainage patterns predict clinical worsening in dural venous sinus thrombosis. J Neurointerv Surg 2018;10:171‑5
  15. Cuadrado‑Godia E. Early neurological deterioration, easy methods to detect it. Indian J Med Res 2015;141:266‑8
  16. Ruiz‑Sandoval JL, Chiquete E, B